NU-MED PLUS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 627.1% | 627.1% | -3,745.3% |
| FY2022 | 206.5% | 206.5% | -163.6% |
| FY2023 | 85.5% | 85.5% | -932.9% |
| FY2024 | 31.8% | 31.8% | -729.2% |
| FY2025 | 20.7% | 20.7% | -710.2% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 627.1% | 627.1% | -3,745.3% |
| FY2022 | 206.5% | 206.5% | -163.6% |
| FY2023 | 85.5% | 85.5% | -932.9% |
| FY2024 | 31.8% | 31.8% | -729.2% |
| FY2025 | 20.7% | 20.7% | -710.2% |